Total Equity - Xeris Biopharma Holdings Inc (NASDAQ:XERS) - Alpha Spread

Xeris Biopharma Holdings Inc
NASDAQ:XERS

Watchlist Manager
Xeris Biopharma Holdings Inc Logo
Xeris Biopharma Holdings Inc
NASDAQ:XERS
Watchlist
Price: 2.965 USD -0.5% Market Closed
Market Cap: 439.6m USD
Have any thoughts about
Xeris Biopharma Holdings Inc?
Write Note

Xeris Biopharma Holdings Inc
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Xeris Biopharma Holdings Inc
Total Equity Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Xeris Biopharma Holdings Inc
NASDAQ:XERS
Total Equity
-$19.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Total Equity
$71.5B
CAGR 3-Years
1%
CAGR 5-Years
3%
CAGR 10-Years
-1%
Bristol-Myers Squibb Co
NYSE:BMY
Total Equity
$17B
CAGR 3-Years
-23%
CAGR 5-Years
1%
CAGR 10-Years
1%
Pfizer Inc
NYSE:PFE
Total Equity
$87.7B
CAGR 3-Years
8%
CAGR 5-Years
8%
CAGR 10-Years
1%
Merck & Co Inc
NYSE:MRK
Total Equity
$43.6B
CAGR 3-Years
9%
CAGR 5-Years
10%
CAGR 10-Years
-1%
Eli Lilly and Co
NYSE:LLY
Total Equity
$13.6B
CAGR 3-Years
28%
CAGR 5-Years
37%
CAGR 10-Years
-3%

See Also

What is Xeris Biopharma Holdings Inc's Total Equity?
Total Equity
-19.3m USD

Based on the financial report for Jun 30, 2024, Xeris Biopharma Holdings Inc's Total Equity amounts to -19.3m USD.

Back to Top